Exercise decreases plasma total homocysteine in overweight young women with polycystic ovary syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 10, 2002, Pages 4496-4501

  Randeva, Harpal S ^a   Lewandowski, Krzysztof C ^b   Drzewoski, Józef ^c   Brooke Wavell, Katherine ^c   O'Callaghan, Chris ^d   Czupryniak, Leszek ^e   Hillhouse, Edward W ^a   Prelevic, Gordana M ^c  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

^c LOUGHBOROUGH UNIVERSITY   (United Kingdom)

^d QUEEN S UNIVERSITY   (Canada)

^e ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE;

ADULT; AEROBIC CAPACITY; AMINO ACID BLOOD LEVEL; ANTHROPOMETRY; ARTICLE; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; EXERCISE; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; OBESITY; OVARY POLYCYSTIC DISEASE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RISK FACTOR;

ADULT; BODY CONSTITUTION; BODY MASS INDEX; EXERCISE; FASTING; FEMALE; HOMOCYSTEINE; HUMANS; LONGITUDINAL STUDIES; OBESITY; OXYGEN CONSUMPTION; POLYCYSTIC OVARY SYNDROME; QUESTIONNAIRES;

FALLOPIA;

EID: 0036775651     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2001-012056     Document Type: Article

References (57)

1. Fonseca V, Guba SC, Fink LM 1999 Hyperhomocysteinemia and the endocrine system: Implications for atherosclerosis and thrombosis. Endocr Rev 20:738-759
2. McCully KS 1996 Homocysteine and vascular disease. Nat Med 2:386-389
3. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I 1991 Hyperhomocystinemia: An independent risk factor for vascular disease. N Engl J Med 324:1149-1155
4. Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE 1997 Plasma homocysteine and mortality in patients with coronary, artery disease. N Engl J Med 337:230-236
5. Boushey CJ, Beresford SA, Omenn GS, Motulky AG 1995 A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of increasing folic acid intakes. JAMA 274:1049-1057
6. Schnyder G, Roffi M, Pin R, Flammer Y, Lange H, Eberli FR, Meier B, Turi ZG, Hess OM 2001 Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N Engl J Med 345:1593-1600
7. Hoogeveen EK, Kostense PJ, Beks PJ, Mackaay AJ, Jakobs C, Bouter LM, Heine RJ, Stehouwer CD 1998 Hyperhomocystinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin dependent diabetes mellitus: A population based study. Arterioscler Thromb Vasc Biol 18:133-138
8. Malinow MR, Levenson J, Giral P, Nieto FJ, Razavian M, Segond P, Simon A 1995 Role of blood pressure, uric acid, and hemorheological parameters on plasma homocysteine concentration. Atherosclerosis 114:175-183
9. Araki A, Sako Y, Ito H 1993 Plasma homocysteine concentrations in Japanese patients with non-insulin-dependent diabetes mellitus: effect of methyl cobalamin treatment. Atherosclerosis 103:149-157
10. Fonseca V, Dicker-Brown A, Ranganathan S, Barnard RJ, Fink L, Kern PA 1998 Effects of insulin resistance on enzymes of homocysteine metabolism in the rat. Diabetes 47:A113
11. Dunaif A 1997 Insulin resistance and the polycystic ovary syndrome: Mechanisms and implications for pathogenesis. Endocr Rev 18:774-800
12. Conway GS, Agrawall R, Betteridge DJ, Jacobs HS 1992 Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clin Endocrinol (Oxf) 37:119-126
13. Guzick DS 1996 Cardiovascular risk in women with polycystic ovarian syndrome. Semin Reprod Endocrinol 14:45-49
14. Rajkhowa M, Bichnell J, Jones M, Clayton RN 1994 Insulin sensitivity in women with polycystic ovary syndrome: Relationship to hyperandrogenemia. Fertil Steril 61:605-612
15. Wild RA, Painter RD, Coulson PB, Carruth KB, Ranney RB 1985 Lipoprotein lipid concentrations as cardiovascular risk in patients with polycystic ovary syndrome. J Clin Enclocrinol Metab 61:946-950
16. Dahlgren E, Johansson S, Lindstedt G, Knutsson F, Oden A, Janson PO, Mattson LA, Crona N, Lundberg PA 1992 Women with polycystic ovary syndrome wedge resected in 1956 to 1965: A long-term follow-up focusing on natural history and circulating hormones. Fertil Steril 57:505-513
17. Zimmermann S, Phillips RA, Dunaif A, Finegood DT, Wilkenfeld C, Ardeljan M, Gorlin R, Krakoff LR 1992 Polycystic ovary syndrome: lack of hypertension despite profound insulin resistance. J Clin Endocrinol Metab 75:508-513
18. Pierpoint T, McKeigue PM, Isaacs AJ, Wild SH, Jacobs HS 1998 Mortality of women with polycystic ovary syndrome at long-term follow-up. J Clin Epidemiol 51:581-586
19. Yarali H, Yildirir A, Aybar F, Kabakci G, Bukumez O, Akgul E, Oto A 2001 Diastolic dysfunction and increased serum homocysteine concentrations may contribute to increased cardiovascular risk in patients with polycystic ovary syndrome. Fertil Steril 76:511-516
20. Ehsani AA, Heath GW, Hagberg JM, Sobel BE, Holloszy JO 1981 Effects of 12 months of intense exercise training on ischemic ST-segment depression in patients with coronary artery disease. Circulation 64:1116-1124
21. Powell KE, Thompson PD, Caspersen CJ, Kendrick JS 1987 Physical activity and the incidence of coronary artery disease. Annu Rev Public Health 8:253-287
22. Hu FB, Sigal RJ, Rich-Edwards JW, Colditz GA, Solomon CG, Willett WC, Speizer FE, Manson JE 1999 Walking compared with vigorous physical activity and risk of type 2 diabetes in women. JAMA 282:1433-1439
23. Lee IM, Rexrode KM, Cook NR, Manson JE, Buring JE 2001 Physical activity and coronary heart disease in women: Is "no pain, no gain" passe? JAMA 285:1447-1454
24. De Cree C, Whiting PH, Cole H 2000 Interactions between homocysteine and nitric oxide during acute submaximal exercise in adult males. Int J Sports Med 21:256-262
25. Bailey DM, Davies B, Baker J 2000 Training in hypoxia: Modulation of metabolic and cardiovascular risk factors in men. Med Sci Sports Exerc 32:1058-1066
26. Balen AH, Conway GS, Kaltsas G, Techatrasak K, Manning PJ, West C, Jacobs HS 1995 Polycystic ovary syndrome: The spectrum of disorder in 1741 patients. Hum Reprod 10:2107-2111
27. Grant JA, Joseph AN, Campagna PD 1999 The prediction of VO2max: A comparison of 7 indirect tests of aerobic power. J Strength Condit Res 13:346-352
28. Maritz JS, Morrison JF, Peter J, Strydom NB, Wyndham CH 1961 A practical method of measuring an individual's maximal oxygen uptake. Ergonomics 4:97-122
29. Drzewoski J, Czupryniak L, Chwatko G, Bald E 2000 Hyperhomocysteinemia in poorly controlled type 2 diabetic patients. Diabetes Nutr Metab 13:319-324
30. Duncan JJ, Gordon NF, Scott CB 1991 Women walking for health and fitnesshow much is enough? JAMA 266:3295-3299
31. Morris JN, Hardman AE 1997 Walking to health. Sports Med 23:306-332
32. Pescatello LS 2000 Physical activity mediates a healthier body weight in the presence of obesity. Br J Sports Med 34:86-93
33. Manson JE, Hu FB, Rich-Edwards JW, Colditz GA, Stampfer MJ, Willett WC, Speizer FE, Hennekens CH 1999 A prospective study of walking as compared with vigorous exercise in the prevention of coronary heart disease in women. N Engl J Med 341:650-658
34. Meigs JB, Jacques PF, Selhub J, Singer DE, Nathan DM, Rifai N, D'Agostino Sr RB, Wilson PW, Framingham Offspring Study 2001 Fasting plasma homocysteine levels in the insulin resistance syndrome. Diabetes Care 24:1403-1410
35. Giltay EJ, Hoogveen EK, Elbers JMH, Gooren LJG, Asscheman H, Stehouwer CDA 1998 Insulin resistance is associated with elevated plasma total homocysteine levels in healthy, non-obese subjects. Atherosclerosis 139:197-198
36. Esmoto M, Kanda H, Shoji T, Kawagishi T, Komatsu M, Mori K, Tahara H, Ishimura E, Inaba M, Okuno Y, Nishizawa Y 2001 Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes. Diabetes Care 24:533-538
37. Godsland IF, Rosankiewicz JR, Proudler AJ, Johnston DG 2001 Plasma total homocysteine concentrations are unrelated to insulin sensitivity and components of the metabolic syndrome in healthy men. J Clin Endocrinol Metab 86:719-723
38. Sheu WH, Lee WJ, Chen YT 2000 Plasma homocysteine concentrations and insulin sensitivity in hypertensive subjects. Am J Hypertens 13:14-20
39. Buysschaert M, Dramais AS, Wallemacq PE, Hermans MP 2000 Hyperhomocysteinemia in type 2 diabetes. Relationship to macroangiopathy, nephropathy and insulin resistance. Diabetes Care 23:1816-1822
40. Abbasi F, Facchini F, Humphreys MH, Reaven GM 1999 Plasma homocysteine concentrations in healthy volunteers are not related to differences in insulin-mediated glucose disposal. Atherosclerosis 146:175-178
41. Laakso M 1993 How good a marker is insulin level for insulin resistance? Am J Epidemiol 139:959-965
42. McAuley KA, Williams SM, Mann JI, Walker RJ, Lewis-Barned NJ, Temple LA, Duncan AW 2001 Diagnosing insulin resistance in the general population. Diabetes Care 24:460-464
43. Bao W, Srinivasan SR, Berenson GS 1996 Persistent elevation of plasma insulin levels is associated with increased cardiovascular risk in children and young adults. The Bogalusa Heart Study. Circulation 93:54-59
44. Wilcken DEL, Gupta VJ 1979 Cysteine-homocysteine mixed disulphide: Differing plasma concentrations in normal men and women. Clin Sci (Lond) 57:211-215
45. Allen RH, Stabler SP, Savage DG, Lindenbaum J 1993 Metabolic abnormalities in cobalamin (vitamin-B12) and folate deficiency. FASEB J 7:1344-1353
46. Nygard O, Vollset SE, Refsum H, Stensvold I, Tverdal A, Nordrehaug JE, Ueland M, Kvale G 1995 Total plasma homocysteine and cardiovascular risk profile. The Hordaland homocysteine study. JAMA 274:1526-1533
47. Hanratty CG, McGrath LT, McAuley DF, Young IS, Johnston GD 2001 The effects of oral methionine and homocysteine on endothelial function. Heart 85:326-330
48. Hambrecht R, Wolf A, Gielen S, Linke A, Hofer J, Erbs S, Schoene N, Schuler G 2000 Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Engl J Med 342:454-460
49. Vermeulen EG, Stehouwer CD, Twisk JW, van den Berg M, de Jong SC, Mackaay AJ, van Campen CM, Visser FC, Jakobs CA, Bulterjis EJ, Rauwerda JA 2000 Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: A randomised, placebo-controlled trial. Lancet 355:517-522
50. Chambers JC, Ueland PM, Obeid OA, Wrigley J, Refsum H, Kooner JS 2000 Improved vascular endothelial function after oral B vitamins: An effect mediated through reduced concentrations of free plasma homocysteine. Circulation 102:2479-2483
51. Perticone F, Ceravolo R, Candigliota M, Ventura G, Iacopino S, Sinopoli F, Mattioli PL 2001 Obesity and body fat distribution induce endothelial dysfunction by oxidative stress. Diabetes 50:159-165
52. Stratton JR, Chandler WL, Schwartz RS, Cerqueira MD, Levy WC, Kahn SE, Larson VG, Cain KC, Beard JC, Abrass IB 1991 Effects of physical conditioning on fibrinolytic variables and fibrinogen in young and old healthy adults. Circulation 83:1692-1697
53. Rauramaa R, Salonen JT, Seppanen K, Salonen R, Venalainen JM, Ihanainen M, Rissanen V 1986 Inhibition of platelet aggregability by moderate-intensity physical exercise: A randomized clinical trial in overweight men. Circulation 74:939-944
54. Welch GN, Loscalzo J 1998 Homocysteine and atherothrombosis. N Engl J Med 338:1042-1050
55. Stehouwer CDA, Gall MA, Hougaard P, Jakobs C, Parving HH 1999 Plasma homocysteine concentration predicts mortality in non-insulin-dependent diabetic patients with and without albuminuria. Kidney Int 55:308-314
56. Ridker PM, Rifai N, Clearfield M, Downs JR, Weis SE, Miles JS, Gotto AM Jr; Air Force/Texas Coronary Atherosclerosis Prevention Study Investigators 2001 Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med. 344:1959-1965
57. Talbott EO, Guzick DS, Sutton-Tyrrell K, McHugh-Pemu KP, Zborowski JV, Remsberg KE, Kuller LH 2000 Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women. Arterioscler Thromb Vasc Biol 20:2414-2421